ASX:CU6
ASX:CU6Pharmaceuticals

ASX Penny Stocks: 3 Picks With Market Caps Under A$700M

The Australian stock market is experiencing a significant upswing, with the ASX 200 reaching new heights amid optimism from positive U.S.-China trade discussions. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their affordability and growth potential. Despite being an older term, these stocks can offer substantial opportunities when backed by strong financials and solid fundamentals.
ASX:NOL
ASX:NOLInsurance

ASX Penny Stocks To Watch In June 2025

The Australian market has recently reached new heights, with the ASX 200 setting a record high driven by strong performances in the Energy, Technology, and Financial sectors. In such a robust market environment, investors often seek opportunities that combine affordability with growth potential. Penny stocks—though an older term—still hold relevance as they typically involve smaller or newer companies that can offer significant returns when backed by solid financials.
ASX:MSB
ASX:MSBBiotechs

Mesoblast (ASX:MSB) Gains 15% In One Week With US FDA Orphan-Drug Approval

Mesoblast (ASX:MSB) experienced a 15% increase in its share price over the past week, largely driven by a significant orphan-drug approval by the U.S. FDA for Ryoncil. This approval, granting seven years of exclusivity for a vital treatment, likely bolstered investor confidence given the strengthened competitive positioning of Mesoblast. While broader market trends saw the S&P 500 and Nasdaq reach new highs amid positive investor sentiment on U.S.-China trade discussions, Mesoblast's specific...